Atlas Trials

A Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult Participants

Clinical trial NCT05994807 · COMPLETED

Trial details

NCT number
NCT05994807
Sponsor
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2023-08-08
Primary completion
2023-09-20
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.